[1]ANASTASIADI Z,LIANOS GD,IGNATIADOU E,et al.Breast cancer in young women:An overview[J].Updates Surg,2017,69(3):313-317.
[2]MERINO BJ,TORRES TM,ROS ML.Breast cancer in the 21st century:From early detection to new therapies[J].Radiologia,2017,59(5):368-379.
[3]BETTAIEB A,PAUL C,PLENCHETTE S,et al.Precision medicine in breast cancer:Reality or utopia[J].Radiol Technol,2017,15(1):139-145.
[4]SHANG L,LIU Z,RONG Y,et al.MRI in breast cancer radiotherapy in prone and supine positions[J].Front Biosci(Landmark Ed),2017,22(6):570-579.
[5]ROGANOVIC D,DJILAS D,VUJNOVIC S,et al.Breast MRI,digital mammography and breast tomosynthesis:Comparison of three methods for early detection of breast cancer[J].Bosn J Basic Med Sci,2015,15(4):64-68.
[6]郑新宇,王秋丽.2015年欧洲肿瘤内科学会《原发性乳腺癌诊断、治疗及随访指南》解读[J].中国实用外科杂志,2016,36(7):763-770.
ZHENG XY,WANG QL.Outlines and summarization of 2015 ESMO clinical practice guideline for diagnosis,treatment and follow-up of primary breast cancer[J].Chinese Journal of Practical Surgery,2016,36(7):763-770.
[7]YEO SK,GUAN JL.Breast cancer:Multiple subtypes within a tumor[J].Trends Cancer,2017,3(11):753-760.
[8]HARBECK N,GNANT M.Breast cancer[J].Lancet,2017,389(10074):1134-1150.
[9]HOUSSAMI N,TURNER RM,MORROW M.Meta-analysis of pre-operative magnetic resonance imaging(MRI) and surgical treatment for breast cancer[J].Breast Cancer Res Treat,2017,165(2):273-283.
[10]PARTRIDGE SC,NISSAN N,RAHBAR H,et al.Diffusion-weighted breast MRI:Clinical applications and emerging techniques[J].J Magn Reson Imaging,2017,45(2):337-355.
[11]XU T,ZHANG L,XU H,et al.Prediction of low-risk breast cancer using quantitative DCE-MRI and its pathological basis[J].Oncotarget,2017,8(69):114360-114370.
[12]张悦,刘万花,王瑞,等.3.0T磁共振不同b值表观扩散系数值与乳腺癌预后因子及分子分型相关性对比研究[J].磁共振成像,2018,9(06):422-426.
ZHANG Y,LIU WH,WANG R,et al.Correlation of apparent diffusion coefficient for different b values with prognostic factors and subtypes of breast carcinoma[J].Chinese Journal of Magnetic Resonance Imaging,2018,9(06):422-426.
[13]刘鸿利,位寒,邹启桂,等.3.0T MRI扩散加权成像表观扩散系数直方图与乳腺浸润性导管癌分子亚型的相关性研究[J].南京医科大学学报(自然科学版),2018,38(02):211-216.
LIU HL,WEI H,ZOU QG,et al.Histogram analysis of apparent diffusion coefficient at 3.0T:Correlation with different subtypes of invasive ductal carcinoma[J].Acta Universitatis Medicinalis Nanjing,2018,38(02):211-216.
[14]王倩,刘万花,王瑞,等.3.0T动态增强MRI定量参数、表观扩散系数与乳腺癌预后因子及分子分型的相关性[J].中国医学影像学杂志,2019,27(07):517-521.
WANG Q,LIU WH,WANG R,et al.Correlation between quantitative parameters,apparent diffusion coefficient of 3.0t dynamic enhanced MRI and prognostic factors as well as molecular types of breast cancer[J].Chinese Journal of Medical Imaging,2019,27(07):517-521.
[15]吴佩琪,赵可,吴磊,等.基于扩散加权成像和动态增强MRI的影像组学特征与乳腺癌分子分型的关系初探[J].中华放射学杂志,2018,52(5):338-343.
WU PQ,ZHAO K,WU L,et al.Correlation of radiomic features based on diffusion weighted imaging and dynamic contrast-enhancement MRI with molecular subtypes of breast cancer[J].Chinese Journal of Radiology,2018,52(5):338-343.
[16]梁翠珊,崔运能,杨伟超,等.基于T2WI影像组学标签预测乳腺癌人表皮生长因子受体2表达状态[J].中国医学影像技术,2019,35(4):555-559.
LIANG CS,CUI YN,YANG WC,et al.T2WI-based radiomics signatures for predicting human epidermal growth factor receptor 2 status in breast cancer[J].Chinese Journal of Medical Imaging Technology,2019,35(4):555-559.
[17]毛锡金,冯艳,曹新山,等.三阴性乳腺癌临床病理及影像学征象分析[J].临床放射学杂志,2014,33(4):503-508.
MAO XJ,FENG Y,CAO XS,et al.Clinical analysis of the pathological and imaging features of triple negative breast cancer[J].Journal of Clinical Radiology,2014,33(4):503-508.